Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What’s ahead for the world’s biggest drugmaker:
Continue reading Pfizer Joins Other Pharmas in Giving a Cautious Outlook
Pfizer Joins Other Pharmas in Giving a Cautious Outlook originally appeared on DailyFinance on Tue, 01 Feb 2011 15:41:00.
Filed Under: Company News, Health Care, Earnings, Pfizer, Bristol-Myers Squibb, Novartis, Eli Lilly, Astrazeneca